Preventive strategy for tumor patients during COVID-19 pandemic
Non-conventional
in English
| WHO COVID | ID: covidwho-291655
ABSTRACT
Tumor patients are the high risk population of being infected by SARS-CoV-2 during the COVID-19 pandemic. In order to reduce the infection risk of the tumor patients and maintain effective antitumor treatment, the preventive strategy for tumor patients in stationary phase, in treatment period, in immunosuppressor treatment, with fever, and involved in clinical trials, are discussed here with consideration of the disease features of the tumor patients and the experience of pharmaceutical care. In addition, suggestions regarding daily protection, diet and follow-up strategy for the tumor patients are provided.
Full text:
Available
Collection:
Databases of international organizations
Database:
WHO COVID
Type of study:
Cohort study
/
Prognostic study
Language:
English
Document Type:
Non-conventional
Similar
MEDLINE
...
LILACS
LIS